Effect of probenecid, verapamil and progesterone on the concentration-dependent and temperature-sensitive human erythrocyte uptake and export of guanosine 3′,5′ cyclic monophosphate (cGMP)
- 1 January 1995
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 55 (8) , 715-721
- https://doi.org/10.3109/00365519509075401
Abstract
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed knowledge about the cellular bio-kinetics of cGMP (synthesis, metabolic conversion and export). In the present study the transport of cGMP in human erythrocytes has been further characterized. The uptake of cGMP was dependent on a concentration gradient and was temperature-sensitive, compatible with passive diffusion. The cGMP export was temperature-sensitive, saturable (Km = 3.4 ± 1.0 μmol 1−1), inhibited by probenecid and verapamil and stimulated by progesterone. The results show that human erythrocytes possess a cGMP transport system similar to that found in other cells and that extracellular levels of cGMP are dependent on intracellular levels, membrane transport and influenced by physiological factors and pharmacological agents.Keywords
This publication has 11 references indexed in Scilit:
- Acute volume expansion in normal pregnancy and preeclampsia: Effects on plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) concentrations and feto‐maternal circulationActa Obstetricia et Gynecologica Scandinavica, 1994
- Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4‐i) and non‐transformed (WI‐38) human cellsInternational Journal of Cancer, 1993
- Efflux of cyclic guanosine 3′,5′-monophosphate from cerebellar slices stimulated by l-glutamate or high K+ or N-methyl-N′-nitro-N-nitrosoguanidineNeuroscience Letters, 1986
- Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.Journal of Clinical Pathology, 1982
- Plasma and Urine Cyclic Guanosine 3′:5′-Monophosphate in Disseminated CancerAnnals of Internal Medicine, 1979
- REGULATION OF GUANOSINE 3′,5′ CYCLIC MONOPHOSPHATE IN THE RAT PINEAL AND POSTERIOR PITUITARY GLANDSJournal of Neurochemistry, 1978
- Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.Journal of Clinical Pathology, 1978
- Hormone-Induced Cyclic Guanosine Monophosphate Secretion from Guinea Pig Pancreatic LobulesScience, 1977
- Urinary Excretion of Cyclic 3′, 5′-Adenosine Monophosphate and Cyclic 3′, 5′-Guanosine Monophosphate During and After PregnancyJournal of Clinical Endocrinology & Metabolism, 1977
- Urinary Cyclic AMP and Cyclic GMP Excretion During the Menstrual CycleHormone and Metabolic Research, 1975